Related Experiment Video
Updated: Mar 17, 2026
Treating Clinical Depression with Repetitive Deep Transcranial Magnetic Stimulation Using the Brainsway H1-coil
Published on: October 4, 2016
Transcranial stimulation as a possible therapeutic proposal in long COVID
Lidiane Palheta Miranda Dos Santos1,2, Julliana Vieira Leão2, Ketelen Yasmim Braga de Moraes Silva1
1Centro de Ciências Biológicas e da Saúde, Universidade do Estado do Pará, Belém, Brazil.
None:
The COVID-19 pandemic triggered an unprecedented global health crisis, with significant repercussions on the mental and neurological health of millions of individuals. Long COVID, characterized by persistent and debilitating symptoms, including chronic fatigue, pain, cognitive impairment, and mood swings, represents a substantial therapeutic challenge. In this context, neuromodulation emerges as a promising therapeutic strategy, offering new perspectives for the management of refractory neurological symptoms. This article aims to critically review the current evidence on the use of neuromodulation in patients with long COVID.
